|
82
|
298
|
3ig7A |
Novel cdk-5 inhibitors - crystal structure of inhibitor efp with cdk-2 |
|
72
|
272
|
3idpA |
B-raf v600e kinase domain in complex with an aminoisoquinoline inhibitor |
|
108
|
343
|
3idbA |
Crystal structure of (108-268)riib:c holoenzyme of camp-dependent protein kinase |
|
94
|
343
|
3idcA |
Crystal structure of (102-265)riib:c holoenzyme of camp-dependent protein kinase |
|
154
|
463
|
3i79A |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) |
|
75
|
273
|
3ii5A |
The complex of wild-type b-raf with pyrazolo pyrimidine inhibitor |
|
101
|
315
|
3iecA |
Helicobacter pylori caga inhibits par1/mark family kinases by mimicking host substrates |
|
159
|
462
|
3i7bA |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with bumped kinase inhibitor nm-pp1 |
|
88
|
286
|
3ik3A |
Ap24534, a pan-bcr-abl inhibitor for chronic myeloid leukemia, potently inhibits the t315i mutant and overcomes mutation-based resistance |
|
93
|
302
|
3i81A |
Crystal structure of insulin-like growth factor 1 receptor (igf-1r-wt) complex with bms-754807 [1-(4-((5-cyclopropyl-1h-pyrazol-3-yl)amino)pyrrolo[2,1-f][1,2,4]triazin-2-yl)-n-(6-fluoro-3-pyridinyl)-2-methyl-l-prolinamide] |
|
106
|
351
|
3i60A |
Crystal structure of erk2 bound to (s)-4-(2-(2-chlorophenylamino)-5-methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-pyrrole-2-carboxamide |
|
116
|
328
|
3i1aA |
Crystal structure of apo spectinomycin phosphotransferase, aph(9)-ia |
|
71
|
262
|
3hyhA |
Crystal structure of the protein kinase domain of yeast amp-activated protein kinase snf1 |
|
101
|
348
|
3hv7A |
Human p38 map kinase in complex with rl38 |
|
87
|
295
|
3i5nA |
Crystal structure of c-met with triazolopyridazine inhibitor 13 |
|
102
|
348
|
3hvcA |
Crystal structure of human p38alpha map kinase |
|
84
|
284
|
3hrcA |
Crystal structure of a mutant of human pdk1 kinase domain in complex with atp |
|
86
|
327
|
3i0qA |
Crystal structure of the amp-bound complex of spectinomycin phosphotransferase, aph(9)-ia |
|
107
|
350
|
3hv3A |
Human p38 map kinase in complex with rl49 |
|
165
|
474
|
3hx4A |
Crystal structure of cdpk1 of toxoplasma gondii, tgme49_101440, in presence of calcium |
|
106
|
347
|
3hp5A |
Crystal structure of human p38alpha complexed with a pyrimidopyridazinone compound |
|
90
|
356
|
3hngA |
Crystal structure of vegfr1 in complex with n-(4-chlorophenyl)-2-((pyridin-4-ylmethyl)amino)benzamide |
|
107
|
350
|
3i5zA |
Crystal structure of erk2 bound to (s)-n-(2-hydroxy-1-phenylethyl)-4-(5-methyl-2-(phenylamino)pyrimidin-4-yl)-1h-pyrrole-2-carboxamide |
|
86
|
285
|
3hrfA |
Crystal structure of human pdk1 kinase domain in complex with an allosteric activator bound to the pif-pocket |
|
100
|
329
|
3i0oA |
Crystal structure of spectinomycin phosphotransferase, aph(9)-ia, in complex with adp and spectinomcyin |
|
110
|
349
|
3hucA |
Human p38 map kinase in complex with rl40 |
|
103
|
410
|
3i6wA |
Structure and activation mechanism of the chk2 dna-damage checkpoint kinase |
|
108
|
349
|
3hv6A |
Human p38 map kinase in complex with rl39 |
|
108
|
349
|
3hrbA |
P38 kinase crystal structure in complex with small molecule inhibitor |
|
107
|
413
|
3i6uA |
Structure and activation mechanism of the chk2 dna-damage checkpoint kinase |
|
106
|
361
|
3i4bA |
Crystal structure of gsk3b in complex with a pyrimidylpyrrole inhibitor |
|
108
|
349
|
3hv5A |
Human p38 map kinase in complex with rl24 |
|
138
|
461
|
3hztA |
Crystal structure of toxoplasma gondii cdpk3, tgme49_105860 |
|
107
|
349
|
3hv4A |
Human p38 map kinase in complex with rl51 |
|
108
|
349
|
3hubA |
Human p38 map kinase in complex with scios-469 |
|
110
|
352
|
3hp2A |
Crystal structure of human p38alpha complexed with a pyridinone compound |
|
81
|
277
|
3h3cA |
Crystal structure of pyk2 in complex with sulfoximine-substituted trifluoromethylpyrimidine analog |
|
80
|
293
|
3hdnA |
Crystal structure of serum and glucocorticoid-regulated kinase 1 in complex with compound 2 |
|
107
|
299
|
3hamA |
Structure of the gentamicin-aph(2")-iia complex |
|
74
|
263
|
3h0yA |
Aurora a in complex with a bisanilinopyrimidine |
|
74
|
281
|
3hmoA |
Crystal structure of human mps1 catalytic domain in complex with the inhibitor staurosporine |
|
80
|
285
|
3h9oA |
Phosphoinositide-dependent protein kinase 1 (pdk-1) in complex with compound 9 |
|
105
|
348
|
3hllA |
Crystal structure of human p38alpha complexed with ph-797804 |
|
105
|
348
|
3hecA |
P38 in complex with imatinib |
|
108
|
333
|
3h30A |
Crystal structure of the catalytic subunit of human protein kinase ck2 with 5,6-dichloro-1-beta-d-ribofuranosylbenzimidazole |
|
99
|
348
|
3hegA |
P38 in complex with sorafenib |
|
102
|
349
|
3ha8A |
The complex structure of the map kinase p38/compound 14b |
|
108
|
332
|
3hkoA |
Crystal structure of a cdpk kinase domain from cryptosporidium parvum, cgd7_40 |
|
80
|
298
|
3hdmA |
Crystal structure of serum and glucocorticoid-regulated kinase 1 in complex with compound 1 |
|
105
|
328
|
3h9rA |
Crystal structure of the kinase domain of type i activin receptor (acvr1) in complex with fkbp12 and dorsomorphin |
